Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | GFER | P55789 | 1/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.62 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.62 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
| ▸ | FOS | P01100 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.56 |
| ▸ | JUN | P05412 | 1/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.56 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30128009 | 1.00 | GAA (0.73) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL9040078 | 0.90 | TSHR (0.73) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL5536197 | 0.87 | ALDH1A1 (0.56) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL13262269 | 0.86 | MAPT (0.59) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL1011093 | 0.86 | GAA (0.73) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL198282 | 0.86 | ALDH1A1 (0.62) | GAAALDH1A1GFERMAPK1LMNA | |
| SCHEMBL7114863 | 0.86 | TSHR (0.77) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL29626821 | 0.86 | ALDH1A1 (0.62) | GAAALDH1A1GFERMAPK1LMNA | |
| SCHEMBL2002022 | 0.85 | ALDH1A1 (0.67) | GAAALDH1A1TSHRNFKB1TDP1 | |
| SCHEMBL30038050 | 0.85 | ALDH1A1 (0.67) | GAAALDH1A1TSHRNFKB1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250384-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | UNIVERSITY OF DELAWARE | 2025-08-07 | — | — | US | claimed |
| US-20230113164-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | UNIVERSITY OF DELAWARE (US) | 2023-04-13 | — | — | US | claimed |
| CN-115697961-A | Preparation method of high-fragrance oxalate | 西姆莱斯有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-11525024-B2 | Bio-based polymers from raw lignocellulosic biomass | UNIVERSITY OF DELAWARE (US) | 2022-12-13 | — | — | US | claimed |
| US-20190144590-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | UNIVERSITY OF DELAWARE (US) | 2019-05-16 | — | — | US | claimed |
| EP-4680210-A1 | MEDICAL PATCH COMPRISING SKIN IRRITATING ACTIVE AGENT | LTS Lohmann Therapie-Systeme AG (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-20250297321-A1 | METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM | INST NAT SANTE RECH MED (FR) | 2025-09-25 | — | — | US | disclosed |
| US-20250250384-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | UNIVERSITY OF DELAWARE | 2025-08-07 | — | — | US | disclosed |
| US-12291592-B2 | Ion-conducting bio-based polymers from raw lignocellulosic biomass | UNIVERSITY OF DELAWARE (US) | 2025-05-06 | — | — | US | disclosed |
| WO-2024189213-A1 | MEDICAL PATCH COMPRISING SKIN IRRITATING ACTIVE AGENT | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2024-09-19 | — | — | WO | disclosed |
| US-RE49934-E1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2024-04-23 | — | — | US | disclosed |
| CN-116535304-A | Erianin analogue, and synthetic method and application thereof | 中国科学院成都生物研究所 | 2023-08-04 | — | — | CN | disclosed |
| WO-2001000603-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2001-01-04 | — | — | WO | disclosed |
| US-6090836-A | DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION | MERCK & CO., INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5304563-A | Lipoxygenase inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 1994-04-19 | — | — | US | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291592-B2 | Ion-conducting bio-based polymers from raw lignocellulosic biomass | ME1, FHIT, BOLA2; BOLA2B | GAA 1447/4885ALDH1A1 317/4885TSHR 4833/4885 |
| US-20250250384-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | ME1, BLVRB, FHIT | GAA 867/4885ALDH1A1 224/4885TSHR 4858/4885 |
| US-20230113164-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | ME1, BLVRB, FHIT | GAA 871/4885ALDH1A1 333/4885TSHR 4845/4885 |
| US-11525024-B2 | Bio-based polymers from raw lignocellulosic biomass | ME1, BLVRB, PLOD1 | GAA 1462/4885ALDH1A1 280/4885TSHR 4884/4885 |
| US-20190144590-A1 | BIO-BASED POLYMERS FROM RAW LIGNOCELLULOSIC BIOMASS | ME1, BLVRB, PLOD1 | GAA 1462/4885ALDH1A1 280/4885TSHR 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.